Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omeros Corp (NQ: OMER )

10.91 +3.18 (+41.14%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,068,714
Open 7.700
Bid (Size) 10.76 (2)
Ask (Size) 11.00 (3)
Prev. Close 7.730
Today's Range 7.460 - 10.99
52wk Range 1.811 - 10.99
Shares Outstanding 62,855,824
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Natural Grocers By Vitamin Cottage, Elastic, Matthews International, Gap And Other Big Stocks Moving Higher On Friday
Via Benzinga
Omeros Corporation Provides Update on Progress Toward BLA Resubmission
From Omeros Corporation
Via Business Wire

Performance

YTD
+231.61%
+231.61%
1 Month
+157.31%
+157.31%
3 Month
+164.16%
+164.16%
6 Month
+229.11%
+229.11%
1 Year
+492.93%
+492.93%

More News

Read More
Neurogene, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
Earnings Outlook For Omeros
Via Benzinga
OMER Stock Earnings: Omeros Misses EPS for Q2 2024
Via InvestorPlace
OMER Stock Earnings: Omeros Misses EPS for Q1 2024
Via InvestorPlace
Omeros Corporation Reports Third Quarter 2024 Financial Results
From Omeros Corporation
Via Business Wire
Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2024
From Omeros Corporation
Via Business Wire
FDA Grants Rare Pediatric Disease Designation to Omeros’ MASP-3 Inhibitor Zaltenibart for Treatment of C3 Glomerulopathy
From Omeros Corporation
Via Business Wire
Omeros Corporation Reports Second Quarter 2024 Financial Results
From Omeros Corporation
Via Business Wire
OMER Stock Earnings: Omeros Misses EPS for Q4 2023
Via InvestorPlace
Omeros Corporation to Announce Second Quarter Financial Results on August 7, 2024
From Omeros Corporation
Via Business Wire
Omeros Announces Webcast Details for Annual Meeting of Shareholders
From Omeros Corporation
Via Business Wire
Omeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028
From Omeros Corporation
Via Business Wire
Crude Oil Moves Higher; Deere Cuts Profit Outlook
Via Benzinga
Exposures Fossil Fuels
Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
US Stocks Edge Higher; Initial Jobless Claims Fall
Via Benzinga
Omeros Corporation Reports First Quarter 2024 Financial Results
From Omeros Corporation
Via Business Wire
Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024
From Omeros Corporation
Via Business Wire
Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress
From Omeros Corporation
Via Business Wire
Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
From Omeros Corporation
Via Business Wire
Earnings Scheduled For April 1, 2024
Via Benzinga
Investor Sentiment Edges Lower, US Stocks Record Gains Last Quarter
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.